Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae.

Weil AA, Ellis CN, Debela MD, Bhuiyan TR, Rashu R, Bourque DL, Khan AI, Chowdhury F, LaRocque RC, Charles RC, Ryan ET, Calderwood SB, Qadri F, Harris JB.

mSphere. 2019 Aug 21;4(4). pii: e00206-19. doi: 10.1128/mSphere.00206-19.

2.

Characteristics and preparation of the last-minute traveler: analysis of vaccine usage in the Global TravEpiNet Consortium.

Yates JA, Rao SR, Walker AT, Esposito DH, Sotir M, LaRocque RC, Ryan ET; Global TravEpiNet Consortium.

J Travel Med. 2019 Sep 2;26(6). pii: taz031. doi: 10.1093/jtm/taz031.

3.

Vibriocidal Titer and Protection From Cholera in Children.

Ritter AS, Chowdhury F, Franke MF, Becker RL, Bhuiyan TR, Khan AI, Saha NC, Ryan ET, Calderwood SB, LaRocque RC, Harris JB, Qadri F, Weil AA.

Open Forum Infect Dis. 2019 Feb 11;6(4):ofz057. doi: 10.1093/ofid/ofz057. eCollection 2019 Apr.

4.

Case 3-2019: A 70-Year-Old Woman with Fever, Headache, and Progressive Encephalopathy.

Zachary KC, LaRocque RC, Gonzalez RG, Branda JA.

N Engl J Med. 2019 Jan 24;380(4):380-387. doi: 10.1056/NEJMcpc1815528. No abstract available.

PMID:
30673553
5.

Climate Change - A Health Emergency.

Solomon CG, LaRocque RC.

N Engl J Med. 2019 Jan 17;380(3):209-211. doi: 10.1056/NEJMp1817067. No abstract available.

6.

Potentially Serious Drug Interactions Resulting From the Pretravel Health Encounter.

Sbaih N, Buss B, Goyal D, Rao SR, Benefield R, Walker AT, Esposito DH, Ryan ET, LaRocque RC, Leung DT; Global TravEpiNet Consortium .

Open Forum Infect Dis. 2018 Oct 22;5(11):ofy266. doi: 10.1093/ofid/ofy266. eCollection 2018 Nov.

7.

The Clinical Impact and Cost-effectiveness of Measles-Mumps-Rubella Vaccination to Prevent Measles Importations Among International Travelers From the United States.

Hyle EP, Fields NF, Fiebelkorn AP, Walker AT, Gastañaduy P, Rao SR, Ryan ET, LaRocque RC, Walensky RP.

Clin Infect Dis. 2019 Jul 2;69(2):306-315. doi: 10.1093/cid/ciy861.

8.

Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh.

Domman D, Chowdhury F, Khan AI, Dorman MJ, Mutreja A, Uddin MI, Paul A, Begum YA, Charles RC, Calderwood SB, Bhuiyan TR, Harris JB, LaRocque RC, Ryan ET, Qadri F, Thomson NR.

Nat Genet. 2018 Jul;50(7):951-955. doi: 10.1038/s41588-018-0150-8. Epub 2018 Jun 25.

9.

Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.

Aktar A, Rahman MA, Afrin S, Akter A, Uddin T, Yasmin T, Sami MIN, Dash P, Jahan SR, Chowdhury F, Khan AI, LaRocque RC, Charles RC, Bhuiyan TR, Mandlik A, Kelly M, Kováč P, Xu P, Calderwood SB, Harris JB, Qadri F, Ryan ET.

PLoS Negl Trop Dis. 2018 Apr 23;12(4):e0006399. doi: 10.1371/journal.pntd.0006399. eCollection 2018 Apr.

10.

Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection.

Midani FS, Weil AA, Chowdhury F, Begum YA, Khan AI, Debela MD, Durand HK, Reese AT, Nimmagadda SN, Silverman JD, Ellis CN, Ryan ET, Calderwood SB, Harris JB, Qadri F, David LA, LaRocque RC.

J Infect Dis. 2018 Jul 13;218(4):645-653. doi: 10.1093/infdis/jiy192.

11.

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

Islam K, Hossain M, Kelly M, Mayo Smith LM, Charles RC, Bhuiyan TR, Kováč P, Xu P, LaRocque RC, Calderwood SB, Simon JK, Chen WH, Haney D, Lock M, Lyon CE, Kirkpatrick BD, Cohen M, Levine MM, Gurwith M, Harris JB, Qadri F, Ryan ET.

PLoS Negl Trop Dis. 2018 Apr 6;12(4):e0006376. doi: 10.1371/journal.pntd.0006376. eCollection 2018 Apr.

12.

Vibrio cholerae genomic diversity within and between patients.

Levade I, Terrat Y, Leducq JB, Weil AA, Mayo-Smith LM, Chowdhury F, Khan AI, Boncy J, Buteau J, Ivers LC, Ryan ET, Charles RC, Calderwood SB, Qadri F, Harris JB, LaRocque RC, Shapiro BJ.

Microb Genom. 2017 Dec;3(12). doi: 10.1099/mgen.0.000142.

13.

Travel Medicine.

Leung DT, LaRocque RC, Ryan ET.

Ann Intern Med. 2018 Jan 2;168(1):ITC1-ITC16. doi: 10.7326/AITC201801020. Review.

PMID:
29297035
14.

Analysis of the Human Mucosal Response to Cholera Reveals Sustained Activation of Innate Immune Signaling Pathways.

Bourque DL, Bhuiyan TR, Genereux DP, Rashu R, Ellis CN, Chowdhury F, Khan AI, Alam NH, Paul A, Hossain L, Mayo-Smith LM, Charles RC, Weil AA, LaRocque RC, Calderwood SB, Ryan ET, Karlsson EK, Qadri F, Harris JB.

Infect Immun. 2018 Jan 22;86(2). pii: e00594-17. doi: 10.1128/IAI.00594-17. Print 2018 Feb.

15.

Travel Characteristics and Pretravel Health Care Among Pregnant or Breastfeeding U.S. Women Preparing for International Travel.

Hagmann SHF, Rao SR, LaRocque RC, Erskine S, Jentes ES, Walker AT, Barnett ED, Chen LH, Hamer DH, Ryan ET; Global TravEpiNet Consortium and the Boston Area Travel Medicine Network.

Obstet Gynecol. 2017 Dec;130(6):1357-1365. doi: 10.1097/AOG.0000000000002360.

16.

Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations.

Hyle EP, Rao SR, Jentes ES, Parker Fiebelkorn A, Hagmann SHF, Taylor Walker A, Walensky RP, Ryan ET, LaRocque RC.

Ann Intern Med. 2017 Jul 18;167(2):77-84. doi: 10.7326/M16-2249. Epub 2017 May 16.

17.

Measuring Success in Global Health Training: Data From 14 Years of a Postdoctoral Fellowship in Infectious Diseases and Tropical Medicine.

Tucker JD, Hughes MA, Durvasula RV, Vinetz JM, McGovern VP, Schultz R, Dunavan CP, Wilson ME, Milner DA, LaRocque RC, Calderwood SB, Guerrant RL, Weller PF, Taylor TE.

Clin Infect Dis. 2017 Jun 15;64(12):1768-1772. doi: 10.1093/cid/cix242.

18.

Preparing Pediatric International Travelers for Travelers' Diarrhea: Insights From the Global TravEpiNet.

Hagmann SH, LaRocque RC, Ryan ET.

Pediatr Infect Dis J. 2017 Feb;36(2):242-243. doi: 10.1097/INF.0000000000001402. No abstract available.

PMID:
28079839
19.

Characteristics of US Travelers to Zika Virus-Affected Countries in the Americas, March 2015-October 2016.

Lammert S, Walker AT, Erskine S, Rao SR, Esposito DH, Ryan ET, Robbins GK, LaRocque RC.

Emerg Infect Dis. 2017 Feb;23(2):324-327. doi: 10.3201/eid2302.161292. Epub 2017 Feb 15.

20.

Refusal of recommended travel-related vaccines among U.S. international travellers in Global TravEpiNet.

Lammert SM, Rao SR, Jentes ES, Fairley JK, Erskine S, Walker AT, Hagmann SH, Sotir MJ, Ryan ET, LaRocque RC.

J Travel Med. 2016 Oct 30;24(1). pii: taw075. Print 2016 Jul.

21.

Medical Considerations before International Travel.

LaRocque RC, Ryan ET.

N Engl J Med. 2016 Oct 13;375(15):e32. doi: 10.1056/NEJMc1610671. No abstract available.

PMID:
27732815
22.

Cholera and ABO Blood Group: Understanding an Ancient Association.

Harris JB, LaRocque RC.

Am J Trop Med Hyg. 2016 Aug 3;95(2):263-264. doi: 10.4269/ajtmh.16-0440. Epub 2016 Jul 11. No abstract available.

23.

O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.

Aktar A, Rahman MA, Afrin S, Faruk MO, Uddin T, Akter A, Sami MIN, Yasmin T, Chowdhury F, Khan AI, Leung DT, LaRocque RC, Charles RC, Bhuiyan TR, Mandlik A, Kelly M, Kováč P, Xu P, Calderwood SB, Harris JB, Qadri F, Ryan ET.

Clin Vaccine Immunol. 2016 May 6;23(5):427-435. doi: 10.1128/CVI.00647-15. Print 2016 May.

24.

Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014.

Chowdhury F, Mather AE, Begum YA, Asaduzzaman M, Baby N, Sharmin S, Biswas R, Uddin MI, LaRocque RC, Harris JB, Calderwood SB, Ryan ET, Clemens JD, Thomson NR, Qadri F.

PLoS Negl Trop Dis. 2015 Nov 12;9(11):e0004183. doi: 10.1371/journal.pntd.0004183. eCollection 2015 Nov.

25.

Pre-Travel Medical Preparation of Business and Occupational Travelers: An Analysis of the Global TravEpiNet Consortium, 2009 to 2012.

Khan NM, Jentes ES, Brown C, Han P, Rao SR, Kozarsky P, Hagmann SH, LaRocque RC, Ryan ET; Global TravEpiNet Consortium (GTEN).

J Occup Environ Med. 2016 Jan;58(1):76-82. doi: 10.1097/JOM.0000000000000602.

26.

Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium.

Schwartz BS, Rosen J, Han PV, Hynes NA, Hagmann SH, Rao SR, Jentes ES, Ryan ET, LaRocque RC, The Global TravEpiNet Consortium.

Am J Trop Med Hyg. 2015 Nov;93(5):1110-1116. doi: 10.4269/ajtmh.15-0185. Epub 2015 Aug 24.

27.

Cholera in pregnancy: Clinical and immunological aspects.

Khan AI, Chowdhury F, Leung DT, Larocque RC, Harris JB, Ryan ET, Calderwood SB, Qadri F.

Int J Infect Dis. 2015 Oct;39:20-4. doi: 10.1016/j.ijid.2015.08.006. Epub 2015 Aug 14.

28.

A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.

Sayeed MA, Bufano MK, Xu P, Eckhoff G, Charles RC, Alam MM, Sultana T, Rashu MR, Berger A, Gonzalez-Escobedo G, Mandlik A, Bhuiyan TR, Leung DT, LaRocque RC, Harris JB, Calderwood SB, Qadri F, Vann WF, Kováč P, Ryan ET.

PLoS Negl Trop Dis. 2015 Jul 8;9(7):e0003881. doi: 10.1371/journal.pntd.0003881. eCollection 2015.

29.

Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh.

Falkard B, Uddin T, Rahman MA, Franke MF, Aktar A, Uddin MI, Bhuiyan TR, Leung DT, Charles RC, Larocque RC, Harris JB, Calderwood SB, Qadri F, Ryan ET.

Am J Trop Med Hyg. 2015 Aug;93(2):244-249. doi: 10.4269/ajtmh.15-0172. Epub 2015 Jun 8.

30.

Gut microbial succession follows acute secretory diarrhea in humans.

David LA, Weil A, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, Begum Y, Qadri F, LaRocque RC, Turnbaugh PJ.

MBio. 2015 May 19;6(3):e00381-15. doi: 10.1128/mBio.00381-15.

31.

Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection.

Ivers LC, Charles RC, Hilaire IJ, Mayo-Smith LM, Teng JE, Jerome JG, Rychert J, LaRocque RC, Xu P, Kovácˇ P, Ryan ET, Qadri F, Almazor CP, Franke MF, Harris JB.

J Infect Dis. 2015 Sep 1;212(5):779-83. doi: 10.1093/infdis/jiv108. Epub 2015 Feb 26.

32.

Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera.

Ellis CN, LaRocque RC, Uddin T, Krastins B, Mayo-Smith LM, Sarracino D, Karlsson EK, Rahman A, Shirin T, Bhuiyan TR, Chowdhury F, Khan AI, Ryan ET, Calderwood SB, Qadri F, Harris JB.

Infect Immun. 2015 Mar;83(3):1089-103. doi: 10.1128/IAI.02765-14. Epub 2015 Jan 5.

33.

Household Transmission of Vibrio cholerae in Bangladesh.

Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, Calderwood SB, Harris JB, Longini IM Jr.

PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3314. doi: 10.1371/journal.pntd.0003314. eCollection 2014 Nov.

34.

Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh.

Weil AA, Begum Y, Chowdhury F, Khan AI, Leung DT, LaRocque RC, Charles RC, Ryan ET, Calderwood SB, Qadri F, Harris JB.

Am J Trop Med Hyg. 2014 Oct;91(4):738-42. doi: 10.4269/ajtmh.14-0095. Epub 2014 Aug 11.

35.

Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet.

Deshpande BR, Rao SR, Jentes ES, Hills SL, Fischer M, Gershman MD, Brunette GW, Ryan ET, LaRocque RC, The Global TravEpiNet Consortium.

Am J Trop Med Hyg. 2014 Oct;91(4):694-698. doi: 10.4269/ajtmh.14-0062. Epub 2014 Jul 28.

36.

Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.

Charles RC, Hilaire IJ, Mayo-Smith LM, Teng JE, Jerome JG, Franke MF, Saha A, Yu Y, Kováč P, Calderwood SB, Ryan ET, LaRocque RC, Almazor CP, Qadri F, Ivers LC, Harris JB.

PLoS Negl Trop Dis. 2014 May 1;8(5):e2828. doi: 10.1371/journal.pntd.0002828. eCollection 2014 May.

37.

Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.

Uddin T, Aktar A, Xu P, Johnson RA, Rahman MA, Leung DT, Afrin S, Akter A, Alam MM, Rahman A, Chowdhury F, Khan AI, Bhuiyan TR, Bufano MK, Rashu R, Yu Y, Wu-Freeman Y, Harris JB, LaRocque RC, Charles RC, Kováč P, Calderwood SB, Ryan ET, Qadri F.

Am J Trop Med Hyg. 2014 May;90(5):873-81. doi: 10.4269/ajtmh.13-0498. Epub 2014 Mar 31.

38.

Cellular and cytokine responses to Salmonella enterica serotype Typhi proteins in patients with typhoid fever in Bangladesh.

Bhuiyan S, Sayeed A, Khanam F, Leung DT, Rahman Bhuiyan T, Sheikh A, Salma U, LaRocque RC, Harris JB, Pacek M, Calderwood SB, LaBaer J, Ryan ET, Qadri F, Charles RC.

Am J Trop Med Hyg. 2014 Jun;90(6):1024-1030. doi: 10.4269/ajtmh.13-0261. Epub 2014 Mar 10.

39.

Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.

Alam MM, Bufano MK, Xu P, Kalsy A, Yu Y, Freeman YW, Sultana T, Rashu MR, Desai I, Eckhoff G, Leung DT, Charles RC, LaRocque RC, Harris JB, Clements JD, Calderwood SB, Qadri F, Vann WF, Kováč P, Ryan ET.

PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2683. doi: 10.1371/journal.pntd.0002683. eCollection 2014 Feb.

40.

Pre-travel preparation of US travelers going abroad to provide humanitarian service, Global TravEpiNet 2009-2011.

Stoney RJ, Jentes ES, Sotir MJ, Kozarsky P, Rao SR, LaRocque RC, Ryan ET, The Global TravEpiNet Consortium.

Am J Trop Med Hyg. 2014 Mar;90(3):553-559. doi: 10.4269/ajtmh.13-0479. Epub 2014 Jan 20.

41.

Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh.

Charles RC, Liang L, Khanam F, Sayeed MA, Hung C, Leung DT, Baker S, Ludwig A, Harris JB, Larocque RC, Calderwood SB, Qadri F, Felgner PL, Ryan ET.

Clin Vaccine Immunol. 2014 Mar;21(3):280-5. doi: 10.1128/CVI.00661-13. Epub 2013 Dec 26.

42.

Pre-exposure rabies vaccination among US international travelers: findings from the global TravEpiNet consortium.

Dolan SB, Jentes ES, Sotir MJ, Han P, Blanton JD, Rao SR, LaRocque RC, Ryan ET; Global TravEpiNet Consortium, Abraham GM, Alvarez S, Ansdell V, Yates JA, Atkins EH, Cahill J, Birich HK, Vitek D, Connor BA, Dismukes R, Kozarsky P, Dosunmu R, Goad JA, Hagmann S, Hale D, Hynes NA, Jacquerioz F, McLellan S, Knouse M, Lee J, LaRocque RC, Ryan ET, Oladele A, Demeke H, Pasinski R, Wheeler AE, Rao SR, Rosen J, Schwartz BS, Stauffer W, Walker P, Vinetz J.

Vector Borne Zoonotic Dis. 2014 Feb;14(2):160-7. doi: 10.1089/vbz.2013.1381. Epub 2013 Dec 20.

43.

Pre-Travel Health Preparation of Pediatric International Travelers: Analysis From the Global TravEpiNet Consortium.

Hagmann S, LaRocque RC, Rao SR, Jentes ES, Sotir MJ, Brunette G, Ryan ET; Global TravEpiNet Consortium.

J Pediatric Infect Dis Soc. 2013 Dec;2(4):327-34. doi: 10.1093/jpids/pit023. Epub 2013 Dec 10.

PMID:
26619495
44.

Economics of malaria prevention in US travelers to West Africa.

Adachi K, Coleman MS, Khan N, Jentes ES, Arguin P, Rao SR, LaRocque RC, Sotir MJ, Brunette G, Ryan ET, Meltzer MI; Global TravEpiNet Consortium.

Clin Infect Dis. 2014 Jan;58(1):11-21. doi: 10.1093/cid/cit570. Epub 2013 Sep 6.

45.

Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh.

Rahman A, Rashu R, Bhuiyan TR, Chowdhury F, Khan AI, Islam K, LaRocque RC, Ryan ET, Wrammert J, Calderwood SB, Qadri F, Harris JB.

Clin Vaccine Immunol. 2013 Oct;20(10):1592-8. doi: 10.1128/CVI.00347-13. Epub 2013 Aug 14.

46.

Identification of immunogenic Salmonella enterica serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, Nepal.

Charles RC, Sultana T, Alam MM, Yu Y, Wu-Freeman Y, Bufano MK, Rollins SM, Tsai L, Harris JB, LaRocque RC, Leung DT, Brooks WA, Nga TV, Dongol S, Basnyat B, Calderwood SB, Farrar J, Khanam F, Gunn JS, Qadri F, Baker S, Ryan ET.

PLoS Negl Trop Dis. 2013 Aug 1;7(8):e2335. doi: 10.1371/journal.pntd.0002335. Print 2013.

47.

Natural selection in a bangladeshi population from the cholera-endemic ganges river delta.

Karlsson EK, Harris JB, Tabrizi S, Rahman A, Shlyakhter I, Patterson N, O'Dushlaine C, Schaffner SF, Gupta S, Chowdhury F, Sheikh A, Shin OS, Ellis C, Becker CE, Stuart LM, Calderwood SB, Ryan ET, Qadri F, Sabeti PC, Larocque RC.

Sci Transl Med. 2013 Jul 3;5(192):192ra86. doi: 10.1126/scitranslmed.3006338.

48.

Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Leung DT, Uddin T, Xu P, Aktar A, Johnson RA, Rahman MA, Alam MM, Bufano MK, Eckhoff G, Wu-Freeman Y, Yu Y, Sultana T, Khanam F, Saha A, Chowdhury F, Khan AI, Charles RC, Larocque RC, Harris JB, Calderwood SB, Kovác P, Qadri F, Ryan ET.

Clin Vaccine Immunol. 2013 Jun;20(6):780-8. doi: 10.1128/CVI.00035-13. Epub 2013 Mar 20.

49.

Identification of in vivo-induced bacterial proteins during human infection with Salmonella enterica serotype Paratyphi A.

Alam MM, Tsai LL, Rollins SM, Sheikh A, Khanam F, Bufano MK, Yu Y, Wu-Freeman Y, Kalsy A, Sultana T, Sayeed MA, Jahan N, LaRocque RC, Harris JB, Leung DT, Brooks WA, Calderwood SB, Charles RC, Qadri F, Ryan ET.

Clin Vaccine Immunol. 2013 May;20(5):712-9. doi: 10.1128/CVI.00054-13. Epub 2013 Mar 13.

50.

Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.

Jentes ES, Han P, Gershman MD, Rao SR, LaRocque RC, Staples JE, Ryan ET, The Global TravEpiNet Consortium.

Am J Trop Med Hyg. 2013 May;88(5):954-961. doi: 10.4269/ajtmh.12-0463. Epub 2013 Mar 4.

Supplemental Content

Loading ...
Support Center